Rapid-Response Covid-19 Test Makers Face Outsize Demand
Doctors, nursing homes and federal officials are scrambling to get rapid-response Covid-19 antigen testing supplies from the two companies that secured emergency approval to produce them, as cases continue to rise in the U.S.
Rapid-response antigen tests make up a small but growing area of Covid-19 testing in the U.S. and are seen as helpful in tamping down outbreaks because they offer faster results than many molecular tests that must be sent to labs for processing. The tests search for virus proteins while other tests look for the viruss genetic material.
Quidel Corp. and Becton Dickinson & Co., the only companies that so far have federal emergency authorization to supply such diagnostic tests, also make machines that process them. The boxlike test-analyzers, which before the pandemic processed tests for ailments such as the flu, are found in doctors offices and nursing homes, allowing facilities to avoid shipping samples to commercial labs for processing. They can deliver results in about 15 minutes and process dozens of samples an hour.
Quidel is struggling to produce enough analyzers to meet demand, while Becton Dickinsons challenge is making enough tests, the companies say.
https://www.msn.com/en-us/money/companies/rapid-response-covid-19-test-makers-face-outsize-demand/ar-BB17RIaR?ocid=NL_ENUS_D1_20200813_5_2
Just how Donny Dotard wants it.